Display options
Cite
Mendelsohn JB, Spiegel P, Grant A, et al. Low levels of viral suppression among refugees and host nationals accessing antiretroviral therapy in a Kenyan refugee camp. Confl Health. 2017;11:11doi: 10.1186/s13031-017-0111-3.
Mendelsohn, J. B., Spiegel, P., Grant, A., Doraiswamy, S., Schilperoord, M., Larke, N., Burton, J. W., Okonji, J. A., Zeh, C., Muhindo, B., Mohammed, I. M., Mukui, I. N., Patterson, N., Sondorp, E., & Ross, D. A. (2017). Low levels of viral suppression among refugees and host nationals accessing antiretroviral therapy in a Kenyan refugee camp. Conflict and health, 1111. https://doi.org/10.1186/s13031-017-0111-3
Mendelsohn, Joshua B, et al. "Low levels of viral suppression among refugees and host nationals accessing antiretroviral therapy in a Kenyan refugee camp." Conflict and health vol. 11 (2017): 11. doi: https://doi.org/10.1186/s13031-017-0111-3
Mendelsohn JB, Spiegel P, Grant A, Doraiswamy S, Schilperoord M, Larke N, Burton JW, Okonji JA, Zeh C, Muhindo B, Mohammed IM, Mukui IN, Patterson N, Sondorp E, Ross DA. Low levels of viral suppression among refugees and host nationals accessing antiretroviral therapy in a Kenyan refugee camp. Confl Health. 2017 May 31;11:11. doi: 10.1186/s13031-017-0111-3. eCollection 2017. PMID: 28572840; PMCID: PMC5450054.
Copy Download .nbib Format: NLM
Share it on

Confl Health. 2017 May 31;11:11. doi: 10.1186/s13031-017-0111-3. eCollection 2017.

Low levels of viral suppression among refugees and host nationals accessing antiretroviral therapy in a Kenyan refugee camp.

Conflict and health

Joshua B Mendelsohn, Paul Spiegel, Alison Grant, Sathyanarayanan Doraiswamy, Marian Schilperoord, Natasha Larke, John Wagacha Burton, Jully A Okonji, Clement Zeh, Bosco Muhindo, Ibrahim M Mohammed, Irene N Mukui, Njogu Patterson, Egbert Sondorp, David A Ross

Affiliations

  1. College of Health Professions, Pace University, New York, NY USA.
  2. MRC Tropical Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  3. Public Health and HIV Unit, United Nations High Commissioner for Refugees, Geneva, Switzerland.
  4. Center for Refugee and Disaster Response, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA.
  5. Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  6. East Africa Regional Office, United Nations High Commissioner for Refugees, Nairobi, Kenya.
  7. Center for Global Health Research and HIV-Research Laboratory, Kenya Medical Research Institute, Kisumu, Kenya.
  8. Clinical and Laboratory Standards Institute, Centers for Disease Control and Prevention Program-Kenya, Kisumu, Kenya.
  9. National AIDS/STD Control Program, Nairobi, Kenya.
  10. Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  11. World Health Organization, Geneva, Switzerland.

PMID: 28572840 PMCID: PMC5450054 DOI: 10.1186/s13031-017-0111-3

Abstract

BACKGROUND: Refugees and host nationals who accessed antiretroviral therapy (ART) in a remote refugee camp in Kakuma, Kenya (2011-2013) were compared on outcome measures that included viral suppression and adherence to ART.

METHODS: This study used a repeated cross-sectional design (

RESULTS: Among eligible adults, 86% (73/85) of refugees and 84% (86/102) of Kenyan host nationals participated in the

CONCLUSIONS: Virologic outcomes among refugees and host nationals were similar but unacceptably low. Slight improvements were observed after a remedial intervention. Virologic monitoring was important for identifying an underperforming ART program in a remote facility that serves refugees alongside host nationals. This work highlights the importance of careful laboratory monitoring of vulnerable populations accessing ART in remote settings.

Keywords: Adherence; Antiretroviral therapy; HIV; Kenya; Migration; Refugee

References

  1. Confl Health. 2012 Oct 31;6(1):9 - PubMed
  2. PLoS One. 2012;7(12):e47391 - PubMed
  3. Top Antivir Med. 2013 Feb-Mar;21(1):6-14 - PubMed
  4. Epidemiology. 2009 Jul;20(4):488-95 - PubMed
  5. PLoS Med. 2007 May;4(5):e129 - PubMed
  6. BMC Infect Dis. 2009 Jun 03;9:81 - PubMed
  7. Lancet. 2010 Jan 9;375(9709):123-31 - PubMed
  8. PLoS One. 2010 Mar 04;5(3):e9538 - PubMed
  9. Lancet. 2010 Jan 23;375(9711):341-5 - PubMed
  10. BMJ. 2009 Feb 17;338:b201 - PubMed
  11. Lancet. 2012 Oct 6;380(9849):1250-8 - PubMed
  12. BMC Public Health. 2014 Oct 04;14:1035 - PubMed
  13. J Gen Intern Med. 2009 Jan;24(1):14-20 - PubMed
  14. J Behav Med. 2016 Dec;39(6):1043-1055 - PubMed
  15. Med Confl Surviv. 2013 Jul-Sep;29(3):198-215 - PubMed
  16. PLoS One. 2010 Apr 28;5(4):e10340 - PubMed
  17. AIDS. 2012 Jan 2;26(1):67-75 - PubMed
  18. Confl Health. 2010 Jun 17;4:12 - PubMed
  19. AIDS Care. 2012;24(6):728-36 - PubMed
  20. Clin Infect Dis. 2012 Jun;54(11):1660-9 - PubMed
  21. Int J STD AIDS. 2009 Dec;20(12):858-62 - PubMed
  22. J Clin Microbiol. 2012 Jun;50(6):1936-42 - PubMed
  23. Am J Clin Nutr. 2007 Feb;85(2):333-45 - PubMed
  24. J Acquir Immune Defic Syndr. 2005 Mar 1;38(3):289-95 - PubMed
  25. Am Psychol. 1991 Sep;46(9):931-46 - PubMed
  26. N Engl J Med. 2011 Aug 11;365(6):493-505 - PubMed
  27. AIDS Behav. 2014 Feb;18(2):323-34 - PubMed
  28. AIDS Res Hum Retroviruses. 2013 Jan;29(1):129-35 - PubMed
  29. Bull World Health Organ. 2013 May 1;91(5):377-385E - PubMed
  30. Lancet Infect Dis. 2010 Mar;10(3):155-66 - PubMed
  31. Clin Infect Dis. 2012 May;54 Suppl 4:S294-9 - PubMed
  32. BMC Public Health. 2009 Aug 11;9:290 - PubMed
  33. AIDS Care. 2007 May;19(5):658-65 - PubMed
  34. AIDS Res Hum Retroviruses. 2012 Sep;28(9):1033-7 - PubMed
  35. Soc Sci Med. 2014 Nov;120:387-95 - PubMed
  36. Clin Infect Dis. 2006 Jun 1;42(11):1608-18 - PubMed

Publication Types

Grant support